Joseph Nixon
Finanzdirektor/CFO bei Locus Biosciences, Inc.
Aktive Positionen von Joseph Nixon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Bioaesthetics Corp.
 Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA. | Direktor/Vorstandsmitglied | 23.08.2023 | - |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Finanzdirektor/CFO | - | - |
Karriereverlauf von Joseph Nixon
Ausbildung von Joseph Nixon
| Case Western Reserve University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Director/Board Member | 1 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 3 |
| Commercial Services | 2 |
| Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Bioaesthetics Corp.
Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA. | Commercial Services |
Locus Biosciences, Inc.
Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC. | Technology Services |
- Börse
- Insiders
- Joseph Nixon
- Erfahrung
